Silence Therapeutics PLC
NASDAQ:SLN
Silence Therapeutics PLC
NASDAQ:SLN
Price:
21.3 USD
-0.56%
Market Closed
Updated:
May 3, 2024
Silence Therapeutics PLC
Cash from Investing Activities
|
Silence Therapeutics PLC
Cash from Investing Activities Peer Comparison
Comparables:
CNTA
AUTL
BCYC
IMCR
GNS
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Silence Therapeutics PLC
NASDAQ:SLN
|
Cash from Investing Activities
-£15m
|
CAGR 3-Years
-48%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Cash from Investing Activities
-$127m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Cash from Investing Activities
-$11m
|
CAGR 3-Years
9%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Cash from Investing Activities
-$2.9m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Cash from Investing Activities
-£5.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Genus PLC
LSE:GNS
|
Cash from Investing Activities
-£21.4m
|
CAGR 3-Years
11%
|
CAGR 5-Years
15%
|
CAGR 10-Years
6%
|
See Also
What is Silence Therapeutics PLC's Cash from Investing Activities?
Cash from Investing Activities
-15m
GBP
-15m
GBP
Based on the financial report for Dec 31, 2019, Silence Therapeutics PLC's Cash from Investing Activities amounts to -15m GBP.
What is Silence Therapeutics PLC's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
-48%
-48%
Over the last year, the Cash from Investing Activities growth was -211%. The average annual Cash from Investing Activities growth rates for Silence Therapeutics PLC have been -48% over the past three years .
You don't have any saved screeners yet
